A First-in-Human, Phase 1 Study of TST003 in Subjects With Solid Tumors

NCT05731271 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

111

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced Solid Tumor
Metastatic Tumor
Colorectal Adenocarcinoma

Interventions

DRUG: TST003

Sponsor

Suzhou Transcenta Therapeutics Co., Ltd.